Concepedia

Krzysztof Misiukiewicz

KM

37

Publications

5.9K

Citations

19

H-Index

2013

Active since

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Mount Sinai Medical Center

Dana-Farber Cancer Institute

Mount Sinai Hospital

Baylor College of Medicine

Krzysztof Misiukiewicz is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, oncology, and head and neck cancer.

ORCID

Top concepts

Publications per year

2013–2025

37

Publications

37

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3K citations · Full text

, , +7

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Ezra E.W. Cohen, Denis Soulières, Christophe Le Tourneau et al. · The Lancet · 2018 · 1.6K citations · Full text

, , +5

Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial

Chrisann Kyi, Vladimir Roudko, Rachel Lubong Sabado et al. · Clinical Cancer Research · 2018 · 127 citations · Full text

Effect of Adding Motolimod to Standard Combination Chemotherapy and Cetuximab Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck

Robert L. Ferris, Nabil F. Saba, Barbara J. Gitlitz et al. · JAMA Oncology · 2018 · 108 citations · Full text

A personalized platform identifies trametinib plus zoledronate for a patient with KRAS-mutant metastatic colorectal cancer

Erdem Bangi, Celina Ang, Peter Smibert et al. · Science Advances · 2019 · 100 citations · Full text

Rows per page

1–5 of 37